SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXM1
|
ENSG00000111206.8 | forkhead box M1 |
TBL1XR1
|
ENSG00000177565.11 | TBL1X receptor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXM1 | hg19_v2_chr12_-_2986107_2986258 | -0.91 | 1.7e-08 | Click! |
TBL1XR1 | hg19_v2_chr3_-_176914238_176914277 | 0.75 | 1.3e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr18_+_61554932 | 26.27 |
ENST00000299502.4
ENST00000457692.1 ENST00000413956.1 |
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
chr12_-_52912901 | 21.31 |
ENST00000551188.1
|
KRT5
|
keratin 5 |
chr19_-_51456344 | 18.62 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
chr3_-_195538760 | 17.75 |
ENST00000475231.1
|
MUC4
|
mucin 4, cell surface associated |
chr10_-_10836919 | 17.36 |
ENST00000602763.1
ENST00000415590.2 ENST00000434919.2 |
SFTA1P
|
surfactant associated 1, pseudogene |
chr18_+_29027696 | 15.72 |
ENST00000257189.4
|
DSG3
|
desmoglein 3 |
chr11_+_5710919 | 15.53 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
chr2_-_113594279 | 14.77 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
chr19_-_51456321 | 14.74 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
chr12_+_8975061 | 14.73 |
ENST00000299698.7
|
A2ML1
|
alpha-2-macroglobulin-like 1 |
chr3_+_189507460 | 14.72 |
ENST00000434928.1
|
TP63
|
tumor protein p63 |
chr19_-_51472823 | 14.42 |
ENST00000310157.2
|
KLK6
|
kallikrein-related peptidase 6 |
chr19_-_51487282 | 14.26 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
chr19_+_52901094 | 14.22 |
ENST00000391788.2
ENST00000436397.1 ENST00000391787.2 ENST00000360465.3 ENST00000494167.2 ENST00000493272.1 |
ZNF528
|
zinc finger protein 528 |
chr11_+_5711010 | 13.81 |
ENST00000454828.1
|
TRIM22
|
tripartite motif containing 22 |
chr11_-_104905840 | 13.77 |
ENST00000526568.1
ENST00000393136.4 ENST00000531166.1 ENST00000534497.1 ENST00000527979.1 ENST00000446369.1 ENST00000353247.5 ENST00000528974.1 ENST00000533400.1 ENST00000525825.1 ENST00000436863.3 |
CASP1
|
caspase 1, apoptosis-related cysteine peptidase |
chr11_-_104972158 | 13.46 |
ENST00000598974.1
ENST00000593315.1 ENST00000594519.1 ENST00000415981.2 ENST00000525374.1 ENST00000375707.1 |
CASP1
CARD16
CARD17
|
caspase 1, apoptosis-related cysteine peptidase caspase recruitment domain family, member 16 caspase recruitment domain family, member 17 |
chr3_-_172241250 | 13.44 |
ENST00000420541.2
ENST00000241261.2 |
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10 |
chr1_+_209602771 | 13.44 |
ENST00000440276.1
|
MIR205HG
|
MIR205 host gene (non-protein coding) |
chr1_-_153538292 | 13.43 |
ENST00000497140.1
ENST00000368708.3 |
S100A2
|
S100 calcium binding protein A2 |
chr4_+_100737954 | 12.96 |
ENST00000296414.7
ENST00000512369.1 |
DAPP1
|
dual adaptor of phosphotyrosine and 3-phosphoinositides |
chr1_+_153330322 | 12.74 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
chrX_-_48326683 | 12.63 |
ENST00000440085.1
|
SLC38A5
|
solute carrier family 38, member 5 |
chr10_-_105845536 | 12.15 |
ENST00000393211.3
|
COL17A1
|
collagen, type XVII, alpha 1 |
chr17_-_7167279 | 12.10 |
ENST00000571932.2
|
CLDN7
|
claudin 7 |
chrX_-_48326764 | 11.98 |
ENST00000413668.1
ENST00000441948.1 |
SLC38A5
|
solute carrier family 38, member 5 |
chr18_+_61254570 | 11.30 |
ENST00000344731.5
|
SERPINB13
|
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
chr3_-_195538728 | 11.29 |
ENST00000349607.4
ENST00000346145.4 |
MUC4
|
mucin 4, cell surface associated |
chr12_-_52887034 | 11.28 |
ENST00000330722.6
|
KRT6A
|
keratin 6A |
chr1_+_89829610 | 11.28 |
ENST00000370456.4
ENST00000535065.1 |
GBP6
|
guanylate binding protein family, member 6 |
chr1_-_28503693 | 11.04 |
ENST00000373857.3
|
PTAFR
|
platelet-activating factor receptor |
chr3_+_189507523 | 11.03 |
ENST00000437221.1
ENST00000392463.2 ENST00000392461.3 ENST00000449992.1 ENST00000456148.1 |
TP63
|
tumor protein p63 |
chr1_+_209602609 | 10.92 |
ENST00000458250.1
|
MIR205HG
|
MIR205 host gene (non-protein coding) |
chr17_-_5487277 | 10.51 |
ENST00000572272.1
ENST00000354411.3 ENST00000577119.1 |
NLRP1
|
NLR family, pyrin domain containing 1 |
chr12_-_6483969 | 10.27 |
ENST00000396966.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
chr1_-_153588334 | 10.23 |
ENST00000476873.1
|
S100A14
|
S100 calcium binding protein A14 |
chr18_-_61329118 | 10.08 |
ENST00000332821.8
ENST00000283752.5 |
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3 |
chrX_-_48328631 | 10.03 |
ENST00000429543.1
ENST00000317669.5 |
SLC38A5
|
solute carrier family 38, member 5 |
chr19_-_51472031 | 10.02 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
chr19_-_51456198 | 9.90 |
ENST00000594846.1
|
KLK5
|
kallikrein-related peptidase 5 |
chr1_+_153003671 | 9.86 |
ENST00000307098.4
|
SPRR1B
|
small proline-rich protein 1B |
chr18_+_61564389 | 9.84 |
ENST00000397996.2
ENST00000418725.1 |
SERPINB10
|
serpin peptidase inhibitor, clade B (ovalbumin), member 10 |
chr12_-_8815404 | 9.68 |
ENST00000359478.2
ENST00000396549.2 |
MFAP5
|
microfibrillar associated protein 5 |
chr10_-_10836865 | 9.62 |
ENST00000446372.2
|
SFTA1P
|
surfactant associated 1, pseudogene |
chr1_+_160709055 | 9.59 |
ENST00000368043.3
ENST00000368042.3 ENST00000458602.2 ENST00000458104.2 |
SLAMF7
|
SLAM family member 7 |
chr18_+_61254534 | 9.58 |
ENST00000269489.5
|
SERPINB13
|
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
chr3_+_189507432 | 9.57 |
ENST00000354600.5
|
TP63
|
tumor protein p63 |
chr6_-_32784687 | 9.49 |
ENST00000447394.1
ENST00000438763.2 |
HLA-DOB
|
major histocompatibility complex, class II, DO beta |
chr1_+_152881014 | 9.47 |
ENST00000368764.3
ENST00000392667.2 |
IVL
|
involucrin |
chr1_-_17307173 | 9.40 |
ENST00000438542.1
ENST00000375535.3 |
MFAP2
|
microfibrillar-associated protein 2 |
chrX_+_135614293 | 9.34 |
ENST00000370634.3
|
VGLL1
|
vestigial like 1 (Drosophila) |
chr8_+_24151553 | 9.29 |
ENST00000265769.4
ENST00000540823.1 ENST00000397649.3 |
ADAM28
|
ADAM metallopeptidase domain 28 |
chr17_-_7166500 | 9.16 |
ENST00000575313.1
ENST00000397317.4 |
CLDN7
|
claudin 7 |
chr11_+_123986069 | 9.03 |
ENST00000456829.2
ENST00000361352.5 ENST00000449321.1 ENST00000392748.1 ENST00000360334.4 ENST00000392744.4 |
VWA5A
|
von Willebrand factor A domain containing 5A |
chr5_-_138862326 | 9.01 |
ENST00000330794.4
|
TMEM173
|
transmembrane protein 173 |
chrX_-_73072534 | 8.87 |
ENST00000429829.1
|
XIST
|
X inactive specific transcript (non-protein coding) |
chr13_-_38172863 | 8.82 |
ENST00000541481.1
ENST00000379743.4 ENST00000379742.4 ENST00000379749.4 ENST00000541179.1 ENST00000379747.4 |
POSTN
|
periostin, osteoblast specific factor |
chr1_-_153029980 | 8.82 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
chr1_+_209859510 | 8.82 |
ENST00000367028.2
ENST00000261465.1 |
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
chr18_+_21529811 | 8.73 |
ENST00000588004.1
|
LAMA3
|
laminin, alpha 3 |
chr19_-_42947121 | 8.68 |
ENST00000601181.1
|
CXCL17
|
chemokine (C-X-C motif) ligand 17 |
chr19_-_51529849 | 8.67 |
ENST00000600362.1
ENST00000453757.3 ENST00000601671.1 |
KLK11
|
kallikrein-related peptidase 11 |
chr10_-_105845674 | 8.63 |
ENST00000353479.5
ENST00000369733.3 |
COL17A1
|
collagen, type XVII, alpha 1 |
chr12_-_6484376 | 8.52 |
ENST00000360168.3
ENST00000358945.3 |
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
chr8_-_125577940 | 8.52 |
ENST00000519168.1
ENST00000395508.2 |
MTSS1
|
metastasis suppressor 1 |
chr22_-_31688381 | 8.48 |
ENST00000487265.2
|
PIK3IP1
|
phosphoinositide-3-kinase interacting protein 1 |
chr7_-_41740181 | 8.48 |
ENST00000442711.1
|
INHBA
|
inhibin, beta A |
chr19_+_42212526 | 8.39 |
ENST00000598976.1
ENST00000435837.2 ENST00000221992.6 ENST00000405816.1 |
CEA
CEACAM5
|
Uncharacterized protein carcinoembryonic antigen-related cell adhesion molecule 5 |
chr12_+_48876275 | 8.38 |
ENST00000314014.2
|
C12orf54
|
chromosome 12 open reading frame 54 |
chr14_-_105420241 | 8.31 |
ENST00000557457.1
|
AHNAK2
|
AHNAK nucleoprotein 2 |
chr2_+_113885138 | 8.20 |
ENST00000409930.3
|
IL1RN
|
interleukin 1 receptor antagonist |
chr6_-_47010061 | 8.12 |
ENST00000371253.2
|
GPR110
|
G protein-coupled receptor 110 |
chr2_+_85804614 | 7.94 |
ENST00000263864.5
ENST00000409760.1 |
VAMP8
|
vesicle-associated membrane protein 8 |
chr17_-_7164410 | 7.92 |
ENST00000574070.1
|
CLDN7
|
claudin 7 |
chr1_+_145439306 | 7.83 |
ENST00000425134.1
|
TXNIP
|
thioredoxin interacting protein |
chr11_+_34642656 | 7.73 |
ENST00000257831.3
ENST00000450654.2 |
EHF
|
ets homologous factor |
chr3_+_40428647 | 7.57 |
ENST00000301825.3
ENST00000439533.1 ENST00000456402.1 |
ENTPD3
|
ectonucleoside triphosphate diphosphohydrolase 3 |
chr18_+_61254221 | 7.56 |
ENST00000431153.1
|
SERPINB13
|
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
chr7_-_121784285 | 7.52 |
ENST00000417368.2
|
AASS
|
aminoadipate-semialdehyde synthase |
chr18_+_21464737 | 7.46 |
ENST00000586751.1
|
LAMA3
|
laminin, alpha 3 |
chr19_-_51531272 | 7.44 |
ENST00000319720.7
|
KLK11
|
kallikrein-related peptidase 11 |
chr10_+_118187379 | 7.43 |
ENST00000369230.3
|
PNLIPRP3
|
pancreatic lipase-related protein 3 |
chr19_-_51531210 | 7.40 |
ENST00000391804.3
|
KLK11
|
kallikrein-related peptidase 11 |
chr12_+_76653611 | 7.39 |
ENST00000550380.1
|
RP11-54A9.1
|
RP11-54A9.1 |
chr10_-_5660118 | 7.38 |
ENST00000427341.1
|
RP11-336A10.4
|
RP11-336A10.4 |
chr19_-_4338838 | 7.34 |
ENST00000594605.1
|
STAP2
|
signal transducing adaptor family member 2 |
chr11_-_104916034 | 7.34 |
ENST00000528513.1
ENST00000375706.2 ENST00000375704.3 |
CARD16
|
caspase recruitment domain family, member 16 |
chr11_+_5712234 | 7.33 |
ENST00000414641.1
|
TRIM22
|
tripartite motif containing 22 |
chr11_-_59633951 | 7.32 |
ENST00000257264.3
|
TCN1
|
transcobalamin I (vitamin B12 binding protein, R binder family) |
chr19_-_53324884 | 7.32 |
ENST00000457749.2
ENST00000414252.2 ENST00000391783.2 |
ZNF28
|
zinc finger protein 28 |
chr11_-_102651343 | 7.31 |
ENST00000279441.4
ENST00000539681.1 |
MMP10
|
matrix metallopeptidase 10 (stromelysin 2) |
chr12_-_8815299 | 7.25 |
ENST00000535336.1
|
MFAP5
|
microfibrillar associated protein 5 |
chr9_-_117853297 | 7.25 |
ENST00000542877.1
ENST00000537320.1 ENST00000341037.4 |
TNC
|
tenascin C |
chr5_+_96211643 | 7.24 |
ENST00000437043.3
ENST00000510373.1 |
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
chr1_-_153013588 | 7.19 |
ENST00000360379.3
|
SPRR2D
|
small proline-rich protein 2D |
chr11_-_58343319 | 7.17 |
ENST00000395074.2
|
LPXN
|
leupaxin |
chr11_+_63304273 | 7.14 |
ENST00000439013.2
ENST00000255688.3 |
RARRES3
|
retinoic acid receptor responder (tazarotene induced) 3 |
chr12_-_8814669 | 7.12 |
ENST00000535411.1
ENST00000540087.1 |
MFAP5
|
microfibrillar associated protein 5 |
chr4_+_47487285 | 7.10 |
ENST00000273859.3
ENST00000504445.1 |
ATP10D
|
ATPase, class V, type 10D |
chr22_-_37640456 | 7.08 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr1_+_159931002 | 7.05 |
ENST00000443364.1
ENST00000423943.1 |
RP11-48O20.4
|
long intergenic non-protein coding RNA 1133 |
chrX_+_56259316 | 6.97 |
ENST00000468660.1
|
KLF8
|
Kruppel-like factor 8 |
chrX_-_80457385 | 6.96 |
ENST00000451455.1
ENST00000436386.1 ENST00000358130.2 |
HMGN5
|
high mobility group nucleosome binding domain 5 |
chr9_-_21995300 | 6.92 |
ENST00000498628.2
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
chr8_+_24151620 | 6.86 |
ENST00000437154.2
|
ADAM28
|
ADAM metallopeptidase domain 28 |
chr5_-_151066514 | 6.83 |
ENST00000538026.1
ENST00000522348.1 ENST00000521569.1 |
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin) |
chr1_-_153588765 | 6.81 |
ENST00000368701.1
ENST00000344616.2 |
S100A14
|
S100 calcium binding protein A14 |
chr14_+_21510385 | 6.79 |
ENST00000298690.4
|
RNASE7
|
ribonuclease, RNase A family, 7 |
chr1_-_156675564 | 6.79 |
ENST00000368220.1
|
CRABP2
|
cellular retinoic acid binding protein 2 |
chr1_-_156675535 | 6.79 |
ENST00000368221.1
|
CRABP2
|
cellular retinoic acid binding protein 2 |
chr10_-_5652705 | 6.79 |
ENST00000425246.1
|
RP11-336A10.5
|
RP11-336A10.5 |
chrX_-_48328551 | 6.78 |
ENST00000376876.3
|
SLC38A5
|
solute carrier family 38, member 5 |
chr1_-_161008697 | 6.78 |
ENST00000318289.10
ENST00000368023.3 ENST00000368024.1 ENST00000423014.2 |
TSTD1
|
thiosulfate sulfurtransferase (rhodanese)-like domain containing 1 |
chr1_-_153113927 | 6.78 |
ENST00000368752.4
|
SPRR2B
|
small proline-rich protein 2B |
chr7_-_143991230 | 6.75 |
ENST00000543357.1
|
ARHGEF35
|
Rho guanine nucleotide exchange factor (GEF) 35 |
chr12_-_15104040 | 6.75 |
ENST00000541644.1
ENST00000545895.1 |
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr1_+_79115503 | 6.70 |
ENST00000370747.4
ENST00000438486.1 ENST00000545124.1 |
IFI44
|
interferon-induced protein 44 |
chr11_+_65779283 | 6.66 |
ENST00000312134.2
|
CST6
|
cystatin E/M |
chr17_-_33760164 | 6.62 |
ENST00000445092.1
ENST00000394562.1 ENST00000447040.2 |
SLFN12
|
schlafen family member 12 |
chr14_+_85996507 | 6.62 |
ENST00000554746.1
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
chr19_+_19976714 | 6.61 |
ENST00000589717.1
ENST00000355650.4 |
ZNF253
|
zinc finger protein 253 |
chr5_-_43397184 | 6.61 |
ENST00000513525.1
|
CCL28
|
chemokine (C-C motif) ligand 28 |
chr19_-_51587502 | 6.61 |
ENST00000156499.2
ENST00000391802.1 |
KLK14
|
kallikrein-related peptidase 14 |
chr19_-_4338783 | 6.60 |
ENST00000601482.1
ENST00000600324.1 |
STAP2
|
signal transducing adaptor family member 2 |
chr19_-_53400813 | 6.59 |
ENST00000595635.1
ENST00000594741.1 ENST00000597111.1 ENST00000593618.1 ENST00000597909.1 |
ZNF320
|
zinc finger protein 320 |
chr12_+_8995832 | 6.58 |
ENST00000541459.1
|
A2ML1
|
alpha-2-macroglobulin-like 1 |
chr12_-_8815215 | 6.58 |
ENST00000544889.1
ENST00000543369.1 |
MFAP5
|
microfibrillar associated protein 5 |
chr12_-_52911718 | 6.49 |
ENST00000548409.1
|
KRT5
|
keratin 5 |
chr22_+_24322322 | 6.48 |
ENST00000215780.5
ENST00000402588.3 |
GSTT2
|
glutathione S-transferase theta 2 |
chr11_-_118135160 | 6.45 |
ENST00000438295.2
|
MPZL2
|
myelin protein zero-like 2 |
chr22_-_31688431 | 6.42 |
ENST00000402249.3
ENST00000443175.1 ENST00000215912.5 ENST00000441972.1 |
PIK3IP1
|
phosphoinositide-3-kinase interacting protein 1 |
chr2_+_113875466 | 6.41 |
ENST00000361779.3
ENST00000259206.5 ENST00000354115.2 |
IL1RN
|
interleukin 1 receptor antagonist |
chr1_+_86889769 | 6.40 |
ENST00000370565.4
|
CLCA2
|
chloride channel accessory 2 |
chr5_-_42811986 | 6.38 |
ENST00000511224.1
ENST00000507920.1 ENST00000510965.1 |
SEPP1
|
selenoprotein P, plasma, 1 |
chr1_-_26680570 | 6.35 |
ENST00000475866.2
|
AIM1L
|
absent in melanoma 1-like |
chr2_+_17721920 | 6.27 |
ENST00000295156.4
|
VSNL1
|
visinin-like 1 |
chr19_-_51487071 | 6.25 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
chr6_+_106959718 | 6.24 |
ENST00000369066.3
|
AIM1
|
absent in melanoma 1 |
chr2_-_151395525 | 6.24 |
ENST00000439275.1
|
RND3
|
Rho family GTPase 3 |
chr12_-_50616382 | 6.18 |
ENST00000552783.1
|
LIMA1
|
LIM domain and actin binding 1 |
chr6_+_30848771 | 6.11 |
ENST00000503180.1
|
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr20_-_45142154 | 6.07 |
ENST00000347606.4
ENST00000457685.2 |
ZNF334
|
zinc finger protein 334 |
chr16_+_55522536 | 6.06 |
ENST00000570283.1
|
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
chr17_+_36584662 | 6.05 |
ENST00000431231.2
ENST00000437668.3 |
ARHGAP23
|
Rho GTPase activating protein 23 |
chr1_+_35220613 | 6.02 |
ENST00000338513.1
|
GJB5
|
gap junction protein, beta 5, 31.1kDa |
chr10_-_28623368 | 5.97 |
ENST00000441595.2
|
MPP7
|
membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) |
chr1_+_87012922 | 5.95 |
ENST00000263723.5
|
CLCA4
|
chloride channel accessory 4 |
chr3_+_122044084 | 5.94 |
ENST00000264474.3
ENST00000479204.1 |
CSTA
|
cystatin A (stefin A) |
chr4_-_15939963 | 5.88 |
ENST00000259988.2
|
FGFBP1
|
fibroblast growth factor binding protein 1 |
chr18_+_61143994 | 5.85 |
ENST00000382771.4
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
chr6_+_106988986 | 5.80 |
ENST00000457437.1
ENST00000535438.1 |
AIM1
|
absent in melanoma 1 |
chr2_-_216240386 | 5.76 |
ENST00000438981.1
|
FN1
|
fibronectin 1 |
chr19_+_42212501 | 5.76 |
ENST00000398599.4
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5 |
chr17_-_39781054 | 5.73 |
ENST00000463128.1
|
KRT17
|
keratin 17 |
chr12_+_14518598 | 5.71 |
ENST00000261168.4
ENST00000538511.1 ENST00000545723.1 ENST00000543189.1 ENST00000536444.1 |
ATF7IP
|
activating transcription factor 7 interacting protein |
chr6_+_18387570 | 5.70 |
ENST00000259939.3
|
RNF144B
|
ring finger protein 144B |
chr16_-_28550348 | 5.70 |
ENST00000324873.6
|
NUPR1
|
nuclear protein, transcriptional regulator, 1 |
chr11_-_87908600 | 5.69 |
ENST00000531138.1
ENST00000526372.1 ENST00000243662.6 |
RAB38
|
RAB38, member RAS oncogene family |
chr11_+_58938903 | 5.68 |
ENST00000532982.1
|
DTX4
|
deltex homolog 4 (Drosophila) |
chr1_+_209602156 | 5.67 |
ENST00000429156.1
ENST00000366437.3 ENST00000603283.1 ENST00000431096.1 |
MIR205HG
|
MIR205 host gene (non-protein coding) |
chr3_+_118905564 | 5.67 |
ENST00000460625.1
|
UPK1B
|
uroplakin 1B |
chr6_-_47009996 | 5.66 |
ENST00000371243.2
|
GPR110
|
G protein-coupled receptor 110 |
chr6_+_30848829 | 5.65 |
ENST00000508317.1
|
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr1_-_230513367 | 5.63 |
ENST00000321327.2
ENST00000525115.1 |
PGBD5
|
piggyBac transposable element derived 5 |
chr11_-_119999539 | 5.61 |
ENST00000541857.1
|
TRIM29
|
tripartite motif containing 29 |
chr2_-_31637560 | 5.61 |
ENST00000379416.3
|
XDH
|
xanthine dehydrogenase |
chr9_+_5450503 | 5.60 |
ENST00000381573.4
ENST00000381577.3 |
CD274
|
CD274 molecule |
chr1_+_181003067 | 5.58 |
ENST00000434571.2
ENST00000367579.3 ENST00000282990.6 ENST00000367580.5 |
MR1
|
major histocompatibility complex, class I-related |
chr16_-_28550320 | 5.51 |
ENST00000395641.2
|
NUPR1
|
nuclear protein, transcriptional regulator, 1 |
chr12_-_10022735 | 5.51 |
ENST00000228438.2
|
CLEC2B
|
C-type lectin domain family 2, member B |
chr18_+_21452804 | 5.49 |
ENST00000269217.6
|
LAMA3
|
laminin, alpha 3 |
chr14_-_61748550 | 5.48 |
ENST00000555868.1
|
TMEM30B
|
transmembrane protein 30B |
chr16_-_82045049 | 5.47 |
ENST00000532128.1
ENST00000328945.5 |
SDR42E1
|
short chain dehydrogenase/reductase family 42E, member 1 |
chr17_-_39743139 | 5.44 |
ENST00000167586.6
|
KRT14
|
keratin 14 |
chr19_-_54676884 | 5.43 |
ENST00000376591.4
|
TMC4
|
transmembrane channel-like 4 |
chr17_-_39769005 | 5.43 |
ENST00000301653.4
ENST00000593067.1 |
KRT16
|
keratin 16 |
chr2_-_216003127 | 5.38 |
ENST00000412081.1
ENST00000272895.7 |
ABCA12
|
ATP-binding cassette, sub-family A (ABC1), member 12 |
chr11_-_13011081 | 5.38 |
ENST00000532541.1
ENST00000526388.1 ENST00000534477.1 ENST00000531402.1 ENST00000527945.1 ENST00000504230.2 |
LINC00958
|
long intergenic non-protein coding RNA 958 |
chr16_+_56659687 | 5.37 |
ENST00000568293.1
ENST00000330439.6 |
MT1E
|
metallothionein 1E |
chr11_-_119993979 | 5.37 |
ENST00000524816.3
ENST00000525327.1 |
TRIM29
|
tripartite motif containing 29 |
chr15_+_43985084 | 5.35 |
ENST00000434505.1
ENST00000411750.1 |
CKMT1A
|
creatine kinase, mitochondrial 1A |
chr16_+_55512742 | 5.34 |
ENST00000568715.1
ENST00000219070.4 |
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
chr1_+_87012753 | 5.34 |
ENST00000370563.3
|
CLCA4
|
chloride channel accessory 4 |
chr12_-_28122980 | 5.30 |
ENST00000395868.3
ENST00000534890.1 |
PTHLH
|
parathyroid hormone-like hormone |
chr1_-_159924006 | 5.30 |
ENST00000368092.3
ENST00000368093.3 |
SLAMF9
|
SLAM family member 9 |
chr19_+_45281118 | 5.29 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
chr21_+_39628655 | 5.26 |
ENST00000398925.1
ENST00000398928.1 ENST00000328656.4 ENST00000443341.1 |
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr18_-_28681950 | 5.26 |
ENST00000251081.6
|
DSC2
|
desmocollin 2 |
chr10_+_5566916 | 5.25 |
ENST00000315238.1
|
CALML3
|
calmodulin-like 3 |
chr5_-_42812143 | 5.23 |
ENST00000514985.1
|
SEPP1
|
selenoprotein P, plasma, 1 |
chrX_+_115567767 | 5.22 |
ENST00000371900.4
|
SLC6A14
|
solute carrier family 6 (amino acid transporter), member 14 |
chr12_+_51318513 | 5.21 |
ENST00000332160.4
|
METTL7A
|
methyltransferase like 7A |
chr7_-_143105941 | 5.21 |
ENST00000275815.3
|
EPHA1
|
EPH receptor A1 |
chr15_+_43885252 | 5.20 |
ENST00000453782.1
ENST00000300283.6 ENST00000437924.1 ENST00000450086.2 |
CKMT1B
|
creatine kinase, mitochondrial 1B |
chr19_+_57742369 | 5.20 |
ENST00000415300.2
ENST00000448930.1 |
AURKC
|
aurora kinase C |
chr4_-_110723134 | 5.18 |
ENST00000510800.1
ENST00000512148.1 |
CFI
|
complement factor I |
chr17_-_33759509 | 5.17 |
ENST00000304905.5
|
SLFN12
|
schlafen family member 12 |
chr6_+_144665237 | 5.16 |
ENST00000421035.2
|
UTRN
|
utrophin |
chr7_+_129932974 | 5.15 |
ENST00000445470.2
ENST00000222482.4 ENST00000492072.1 ENST00000473956.1 ENST00000493259.1 ENST00000486598.1 |
CPA4
|
carboxypeptidase A4 |
chr5_-_39274617 | 5.12 |
ENST00000510188.1
|
FYB
|
FYN binding protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.6 | 63.8 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
9.7 | 38.9 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
9.5 | 28.4 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
7.0 | 28.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
6.3 | 18.8 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
4.2 | 12.7 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
4.2 | 4.2 | GO:0002784 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
3.7 | 11.0 | GO:1904300 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
3.5 | 10.4 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
3.3 | 10.0 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
3.3 | 3.3 | GO:0018277 | protein deamination(GO:0018277) |
3.2 | 12.7 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
3.1 | 9.4 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
3.1 | 15.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
2.9 | 14.7 | GO:1904448 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
2.8 | 11.0 | GO:0060901 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
2.7 | 19.0 | GO:0071461 | cellular response to redox state(GO:0071461) |
2.5 | 92.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
2.5 | 9.9 | GO:0035425 | autocrine signaling(GO:0035425) |
2.5 | 12.4 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
2.5 | 44.4 | GO:0015816 | glycine transport(GO:0015816) |
2.4 | 16.8 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
2.4 | 14.1 | GO:1902957 | negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
2.3 | 6.9 | GO:1904235 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
2.3 | 2.3 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
2.3 | 6.8 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
2.3 | 6.8 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
2.2 | 2.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
2.2 | 8.8 | GO:0031049 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
2.2 | 17.5 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
2.1 | 8.6 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
2.1 | 25.5 | GO:0070487 | monocyte aggregation(GO:0070487) |
2.0 | 18.2 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
2.0 | 5.9 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
1.9 | 36.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.8 | 10.9 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.8 | 5.3 | GO:0033242 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
1.7 | 33.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.7 | 8.7 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
1.7 | 1.7 | GO:1900229 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
1.7 | 5.0 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
1.7 | 14.9 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
1.6 | 4.9 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
1.6 | 4.9 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
1.6 | 8.2 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
1.6 | 11.4 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
1.6 | 6.5 | GO:0035627 | ceramide transport(GO:0035627) |
1.6 | 6.5 | GO:0046110 | xanthine metabolic process(GO:0046110) |
1.6 | 12.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
1.6 | 4.7 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
1.6 | 4.7 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.6 | 4.7 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
1.6 | 6.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.5 | 6.2 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
1.5 | 7.7 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
1.5 | 9.2 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
1.5 | 6.1 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
1.5 | 3.0 | GO:0015917 | aminophospholipid transport(GO:0015917) |
1.5 | 8.9 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
1.4 | 10.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.4 | 10.0 | GO:1903575 | cornified envelope assembly(GO:1903575) |
1.4 | 2.9 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.4 | 4.3 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
1.4 | 8.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.4 | 4.2 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
1.4 | 2.7 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
1.4 | 2.7 | GO:1903203 | regulation of oxidative stress-induced neuron death(GO:1903203) |
1.4 | 8.2 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
1.4 | 4.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.3 | 4.0 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
1.3 | 6.7 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
1.3 | 12.0 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
1.3 | 5.3 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
1.3 | 2.6 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
1.3 | 29.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
1.3 | 8.8 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.2 | 18.6 | GO:0001660 | fever generation(GO:0001660) |
1.2 | 6.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.2 | 8.5 | GO:0030035 | microspike assembly(GO:0030035) |
1.2 | 4.8 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.2 | 3.6 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
1.2 | 13.0 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.2 | 3.5 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
1.2 | 7.0 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
1.2 | 4.6 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
1.1 | 4.6 | GO:1904800 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
1.1 | 2.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
1.1 | 3.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.1 | 3.3 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
1.1 | 16.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.1 | 6.6 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
1.1 | 12.0 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.1 | 1.1 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
1.1 | 10.9 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.1 | 2.2 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
1.1 | 4.3 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
1.0 | 1.0 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
1.0 | 2.1 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
1.0 | 6.2 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
1.0 | 10.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.0 | 8.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.0 | 11.1 | GO:0048102 | autophagic cell death(GO:0048102) |
1.0 | 2.0 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
1.0 | 3.0 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
1.0 | 11.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
1.0 | 4.0 | GO:0044147 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
1.0 | 67.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
1.0 | 9.8 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.0 | 2.9 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.0 | 4.9 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
1.0 | 4.9 | GO:0021557 | optic cup structural organization(GO:0003409) oculomotor nerve development(GO:0021557) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
1.0 | 5.8 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
1.0 | 3.9 | GO:1904647 | response to rotenone(GO:1904647) |
1.0 | 26.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
1.0 | 6.7 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
1.0 | 7.7 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.0 | 2.9 | GO:0035456 | response to interferon-beta(GO:0035456) |
1.0 | 6.7 | GO:0008218 | bioluminescence(GO:0008218) |
1.0 | 12.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.9 | 3.8 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.9 | 5.6 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.9 | 5.5 | GO:0030421 | defecation(GO:0030421) |
0.9 | 14.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.9 | 2.7 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.9 | 30.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.9 | 3.6 | GO:0060166 | olfactory pit development(GO:0060166) |
0.9 | 3.6 | GO:0070895 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
0.9 | 2.7 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.9 | 5.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.9 | 3.6 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.9 | 2.7 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.9 | 2.7 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.9 | 3.6 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.9 | 0.9 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.9 | 7.0 | GO:1905068 | arterial endothelial cell fate commitment(GO:0060844) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.9 | 44.7 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.9 | 0.9 | GO:0060594 | mammary gland specification(GO:0060594) |
0.9 | 6.0 | GO:0001781 | neutrophil apoptotic process(GO:0001781) |
0.9 | 2.6 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.9 | 0.9 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.9 | 12.8 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.8 | 4.2 | GO:0097475 | motor neuron migration(GO:0097475) |
0.8 | 1.7 | GO:0006067 | ethanol metabolic process(GO:0006067) |
0.8 | 2.5 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.8 | 5.0 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.8 | 3.3 | GO:0060168 | regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.8 | 2.5 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.8 | 0.8 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.8 | 5.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.8 | 3.3 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.8 | 4.1 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.8 | 4.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.8 | 2.4 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.8 | 7.2 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.8 | 0.8 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.8 | 3.2 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.8 | 4.0 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.8 | 18.3 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.8 | 3.2 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.8 | 6.3 | GO:0030578 | PML body organization(GO:0030578) |
0.8 | 3.9 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.8 | 15.7 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.8 | 1.6 | GO:0006788 | heme oxidation(GO:0006788) |
0.8 | 1.5 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.8 | 1.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.8 | 4.6 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.8 | 19.9 | GO:0002347 | response to tumor cell(GO:0002347) |
0.8 | 6.1 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.8 | 0.8 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.8 | 12.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.8 | 0.8 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.8 | 3.0 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.7 | 1.5 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.7 | 13.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.7 | 3.0 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
0.7 | 2.2 | GO:1903674 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.7 | 3.7 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.7 | 3.7 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.7 | 2.9 | GO:0060935 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.7 | 5.8 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.7 | 1.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.7 | 2.2 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.7 | 2.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.7 | 2.2 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
0.7 | 5.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.7 | 2.2 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.7 | 4.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.7 | 7.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.7 | 4.3 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.7 | 7.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.7 | 2.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.7 | 1.4 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.7 | 2.1 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.7 | 1.4 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.7 | 4.2 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.7 | 34.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.7 | 3.5 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.7 | 6.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.7 | 3.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.7 | 3.4 | GO:0060174 | limb bud formation(GO:0060174) |
0.7 | 2.0 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.7 | 1.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.7 | 2.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.7 | 5.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.7 | 34.3 | GO:0032732 | positive regulation of interleukin-1 production(GO:0032732) |
0.7 | 0.7 | GO:1901532 | regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.7 | 10.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.7 | 3.9 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.7 | 2.0 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.6 | 5.8 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.6 | 4.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.6 | 0.6 | GO:0006789 | bilirubin conjugation(GO:0006789) |
0.6 | 1.9 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
0.6 | 2.6 | GO:0042441 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.6 | 3.2 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.6 | 3.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.6 | 0.6 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.6 | 1.9 | GO:0008052 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.6 | 2.5 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.6 | 1.9 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.6 | 8.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.6 | 1.9 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.6 | 0.6 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.6 | 3.1 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.6 | 1.2 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.6 | 7.4 | GO:0021759 | globus pallidus development(GO:0021759) |
0.6 | 0.6 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.6 | 6.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.6 | 1.8 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.6 | 1.8 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.6 | 3.1 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.6 | 12.8 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.6 | 4.8 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.6 | 1.8 | GO:0070637 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.6 | 7.8 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.6 | 2.4 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.6 | 1.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.6 | 2.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.6 | 6.0 | GO:0060022 | hard palate development(GO:0060022) |
0.6 | 3.6 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.6 | 2.4 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.6 | 1.2 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.6 | 21.2 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.6 | 10.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.6 | 1.8 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.6 | 2.3 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
0.6 | 5.8 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.6 | 1.7 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.6 | 7.6 | GO:0007172 | signal complex assembly(GO:0007172) |
0.6 | 1.7 | GO:0033007 | negative regulation of mast cell activation involved in immune response(GO:0033007) |
0.6 | 4.1 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.6 | 4.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.6 | 2.3 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.6 | 2.9 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.6 | 3.5 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.6 | 6.9 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.6 | 9.7 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.6 | 2.9 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.6 | 1.1 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.6 | 2.8 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.6 | 2.8 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.6 | 3.9 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.6 | 5.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.6 | 1.7 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.6 | 0.6 | GO:1990637 | response to prolactin(GO:1990637) |
0.6 | 0.6 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.6 | 2.8 | GO:1901545 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
0.6 | 2.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.5 | 1.6 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.5 | 0.5 | GO:0060021 | palate development(GO:0060021) |
0.5 | 0.5 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.5 | 5.9 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.5 | 4.9 | GO:0003383 | apical constriction(GO:0003383) |
0.5 | 1.6 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.5 | 4.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.5 | 1.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.5 | 3.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.5 | 9.0 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.5 | 6.9 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.5 | 1.6 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.5 | 22.8 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.5 | 2.1 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.5 | 9.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.5 | 1.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.5 | 2.1 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.5 | 2.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.5 | 0.5 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.5 | 2.1 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.5 | 3.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 7.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.5 | 0.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.5 | 1.6 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.5 | 2.6 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.5 | 0.5 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.5 | 4.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.5 | 7.2 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.5 | 0.5 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.5 | 3.6 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.5 | 1.5 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.5 | 4.6 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.5 | 1.5 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.5 | 6.0 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.5 | 4.0 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.5 | 1.5 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.5 | 0.5 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.5 | 2.5 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.5 | 3.9 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.5 | 1.0 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.5 | 1.0 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.5 | 2.9 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.5 | 0.5 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.5 | 0.5 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.5 | 1.9 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.5 | 1.4 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
0.5 | 9.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.5 | 2.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.5 | 0.5 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.5 | 4.8 | GO:0051013 | microtubule severing(GO:0051013) |
0.5 | 15.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.5 | 9.5 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.5 | 4.7 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.5 | 0.9 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.5 | 5.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.5 | 2.4 | GO:1990910 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
0.5 | 1.9 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.5 | 5.2 | GO:0099639 | neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
0.5 | 1.4 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.5 | 3.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.5 | 0.5 | GO:1903413 | cellular response to bile acid(GO:1903413) |
0.5 | 2.3 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.5 | 6.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.5 | 0.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.5 | 1.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.5 | 1.8 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.5 | 0.5 | GO:0007632 | visual behavior(GO:0007632) |
0.4 | 0.4 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.4 | 2.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.4 | 3.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.4 | 0.9 | GO:2000742 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.4 | 0.4 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.4 | 6.7 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.4 | 1.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.4 | 2.7 | GO:0070417 | cellular response to cold(GO:0070417) |
0.4 | 4.9 | GO:0018377 | protein myristoylation(GO:0018377) |
0.4 | 2.2 | GO:0070944 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.4 | 2.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.4 | 6.6 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.4 | 1.8 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.4 | 7.4 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.4 | 1.3 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.4 | 0.4 | GO:0048254 | snoRNA localization(GO:0048254) |
0.4 | 1.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.4 | 0.4 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.4 | 1.7 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.4 | 1.3 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
0.4 | 1.7 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.4 | 1.7 | GO:0036269 | swimming behavior(GO:0036269) |
0.4 | 3.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 1.7 | GO:0030539 | male genitalia development(GO:0030539) |
0.4 | 3.0 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.4 | 0.9 | GO:1904796 | regulation of core promoter binding(GO:1904796) |
0.4 | 3.0 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.4 | 4.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.4 | 1.3 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.4 | 2.1 | GO:0071442 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.4 | 10.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.4 | 0.4 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.4 | 1.3 | GO:0042938 | dipeptide transport(GO:0042938) |
0.4 | 1.7 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.4 | 1.3 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.4 | 3.3 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.4 | 4.6 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.4 | 5.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 1.2 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.4 | 3.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 4.5 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.4 | 1.6 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.4 | 4.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.4 | 2.9 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.4 | 2.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.4 | 1.2 | GO:0021503 | neural fold bending(GO:0021503) |
0.4 | 0.8 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.4 | 2.8 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.4 | 3.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.4 | 5.7 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.4 | 4.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.4 | 0.8 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.4 | 4.0 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.4 | 3.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.4 | 0.8 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.4 | 0.8 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.4 | 4.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 2.0 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 4.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.4 | 0.8 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.4 | 1.6 | GO:0090094 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.4 | 3.5 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.4 | 5.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.4 | 0.8 | GO:0071030 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
0.4 | 0.8 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.4 | 3.1 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 0.8 | GO:0052553 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.4 | 7.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.4 | 0.8 | GO:0035106 | operant conditioning(GO:0035106) |
0.4 | 1.5 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.4 | 2.6 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.4 | 1.9 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.4 | 2.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 2.6 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.4 | 1.1 | GO:0042214 | terpene metabolic process(GO:0042214) |
0.4 | 0.8 | GO:0001300 | chronological cell aging(GO:0001300) |
0.4 | 1.5 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.4 | 7.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.4 | 3.4 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.4 | 3.0 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.4 | 1.1 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
0.4 | 4.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.4 | 0.4 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.4 | 4.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.4 | 2.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.4 | 4.4 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.4 | 4.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 5.5 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.4 | 4.4 | GO:0007614 | short-term memory(GO:0007614) |
0.4 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.4 | 2.6 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.4 | 1.8 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 1.8 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.4 | 1.5 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
0.4 | 2.2 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.4 | 4.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.4 | 1.1 | GO:0044861 | protein localization to plasma membrane raft(GO:0044860) protein transport into plasma membrane raft(GO:0044861) |
0.4 | 2.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.4 | 4.3 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.4 | 0.4 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.4 | 3.2 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.4 | 1.4 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.4 | 0.7 | GO:0001842 | neural fold formation(GO:0001842) B-1 B cell homeostasis(GO:0001922) neural fold elevation formation(GO:0021502) positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
0.4 | 2.8 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.4 | 1.4 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.4 | 3.2 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.4 | 1.1 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.4 | 2.8 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 4.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 0.7 | GO:0097205 | glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
0.3 | 3.8 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.3 | 1.0 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.3 | 1.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.3 | 1.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.3 | 1.0 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.3 | 2.7 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 1.0 | GO:0071226 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
0.3 | 0.7 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.3 | 2.7 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.3 | 1.7 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
0.3 | 6.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.3 | 4.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.3 | 1.0 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.3 | 1.0 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.3 | 0.7 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
0.3 | 2.7 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 4.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.3 | 0.3 | GO:1903306 | negative regulation of regulated secretory pathway(GO:1903306) |
0.3 | 0.7 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.3 | 3.3 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.3 | 0.7 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.3 | 1.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.3 | 1.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.3 | 0.3 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.3 | 0.7 | GO:0001923 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.3 | 1.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.3 | 1.3 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.3 | 2.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.3 | 1.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.3 | 2.3 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.3 | 3.2 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.3 | 5.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 1.3 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.3 | 4.5 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.3 | 6.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.3 | 0.3 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.3 | 2.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 | 1.6 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.3 | 1.3 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 4.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 1.6 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 1.3 | GO:0097581 | lamellipodium organization(GO:0097581) |
0.3 | 1.3 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.3 | 1.0 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.3 | 0.3 | GO:1900543 | negative regulation of purine nucleotide metabolic process(GO:1900543) |
0.3 | 1.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.3 | 11.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 0.9 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.3 | 0.6 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.3 | 1.6 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.3 | 4.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 20.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 1.9 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.3 | 0.6 | GO:1901656 | glycoside transport(GO:1901656) |
0.3 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.3 | 0.9 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.3 | 1.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 0.6 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.3 | 3.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.3 | 0.9 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.3 | 1.8 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) response to host(GO:0075136) |
0.3 | 1.5 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.3 | 0.9 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 1.5 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.3 | 0.9 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
0.3 | 2.1 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.3 | 1.5 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.3 | 4.5 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.3 | 1.2 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.3 | 1.5 | GO:0042048 | olfactory behavior(GO:0042048) |
0.3 | 0.9 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.3 | 0.6 | GO:0010266 | response to vitamin B1(GO:0010266) cellular response to lead ion(GO:0071284) |
0.3 | 1.8 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.3 | 3.6 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 1.8 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.3 | 0.6 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.3 | 0.3 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.3 | 2.9 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.3 | 14.6 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.3 | 3.2 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.3 | 0.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 0.3 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.3 | 28.3 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.3 | 0.6 | GO:0007549 | dosage compensation(GO:0007549) |
0.3 | 0.3 | GO:0021764 | amygdala development(GO:0021764) |
0.3 | 21.0 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.3 | 4.0 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.3 | 1.7 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.3 | 2.9 | GO:0072189 | ureter development(GO:0072189) |
0.3 | 0.6 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.3 | 0.6 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 8.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 0.3 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.3 | 1.7 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 0.6 | GO:1904978 | regulation of endosome organization(GO:1904978) |
0.3 | 0.8 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.3 | 2.0 | GO:0098704 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.3 | 0.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 1.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.3 | 2.5 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.3 | 0.8 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.3 | 1.9 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 2.2 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.3 | 0.6 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.3 | 7.7 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.3 | 3.6 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 22.0 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.3 | 3.6 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 0.8 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.3 | 0.8 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.3 | 3.6 | GO:0009642 | response to light intensity(GO:0009642) |
0.3 | 3.0 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.3 | 0.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 3.0 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.3 | 0.5 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.3 | 5.7 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.3 | 1.6 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.3 | 0.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 3.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 0.8 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.3 | 1.6 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.3 | 1.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.3 | 4.3 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.3 | 8.3 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.3 | 2.1 | GO:0061053 | somite development(GO:0061053) |
0.3 | 3.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.3 | 1.1 | GO:0044728 | DNA methylation or demethylation(GO:0044728) |
0.3 | 4.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 0.8 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.3 | 3.4 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.3 | 0.8 | GO:0009405 | pathogenesis(GO:0009405) |
0.3 | 0.5 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.3 | 0.3 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.3 | 6.0 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.3 | 2.6 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 1.0 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.3 | 0.5 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.3 | 1.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 0.5 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.3 | 2.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 1.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.3 | 1.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.3 | 28.6 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 1.3 | GO:1904383 | response to sodium phosphate(GO:1904383) |
0.3 | 7.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 0.5 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.3 | 7.9 | GO:0002076 | osteoblast development(GO:0002076) |
0.3 | 1.5 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.3 | 4.8 | GO:0060004 | reflex(GO:0060004) |
0.3 | 3.8 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.3 | 0.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 2.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.3 | 4.8 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.3 | 0.8 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.3 | 6.5 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.3 | 2.8 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.3 | 1.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.3 | 0.8 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.3 | 2.5 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.3 | 0.8 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 0.5 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.2 | 1.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 0.7 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.2 | 1.0 | GO:1990144 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.2 | 2.2 | GO:0035733 | hepatic stellate cell activation(GO:0035733) fibroblast activation(GO:0072537) regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 1.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 3.7 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 3.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 4.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 1.7 | GO:0046449 | creatinine metabolic process(GO:0046449) |
0.2 | 2.7 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.2 | 2.7 | GO:0003360 | brainstem development(GO:0003360) |
0.2 | 3.1 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.2 | 1.9 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 3.9 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.2 | 1.0 | GO:1900175 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.2 | 1.0 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 2.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.5 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 1.7 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.7 | GO:0016240 | autophagosome docking(GO:0016240) |
0.2 | 0.2 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.7 | GO:0006171 | cAMP biosynthetic process(GO:0006171) |
0.2 | 2.6 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
0.2 | 2.3 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 1.6 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.2 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.2 | 0.2 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.2 | 0.7 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.2 | 0.2 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
0.2 | 0.9 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.2 | 3.7 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.2 | 0.2 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.2 | 0.9 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 1.1 | GO:0002792 | negative regulation of peptide secretion(GO:0002792) |
0.2 | 0.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 1.4 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.2 | 1.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 0.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 0.5 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.2 | 2.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 0.9 | GO:0051413 | response to cortisone(GO:0051413) |
0.2 | 2.9 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.2 | 0.9 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.2 | 1.5 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
0.2 | 7.1 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 1.5 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.2 | 0.9 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.2 | 1.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 2.6 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.7 | GO:0044805 | late nucleophagy(GO:0044805) |
0.2 | 1.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 1.9 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 1.3 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.2 | 0.9 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 2.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 3.6 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.2 | 0.8 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.2 | 1.5 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.2 | 8.9 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 1.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.4 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 0.6 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
0.2 | 0.4 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.2 | 1.0 | GO:0070669 | interleukin-2-mediated signaling pathway(GO:0038110) response to interleukin-2(GO:0070669) cellular response to interleukin-2(GO:0071352) |
0.2 | 0.8 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.2 | 5.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.2 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.2 | 0.2 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.2 | 0.8 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.2 | 2.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.8 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.2 | 0.6 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 0.6 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.2 | 10.8 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.2 | 1.9 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 2.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 1.0 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.2 | 14.7 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 1.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 0.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 | 3.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.6 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.2 | 6.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.2 | 0.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 1.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 0.8 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.2 | 2.8 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 1.0 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.2 | 1.4 | GO:0015824 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
0.2 | 6.2 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.2 | 0.8 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.2 | 0.2 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.2 | 1.0 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.2 | 1.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 0.6 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.2 | 1.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 1.0 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.2 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.2 | 0.8 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.2 | 2.9 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 0.6 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.2 | 4.8 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.2 | 2.5 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.2 | 0.2 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.2 | 1.0 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.2 | 0.4 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.2 | 0.8 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 4.9 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.2 | 1.3 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.2 | 1.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 0.4 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.2 | 0.4 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.2 | 0.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.6 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.2 | 0.6 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
0.2 | 0.4 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.2 | 5.6 | GO:0016573 | histone acetylation(GO:0016573) |
0.2 | 0.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 2.6 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 1.5 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.2 | 0.9 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 9.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.9 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.2 | 1.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 0.4 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.2 | 2.3 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.2 | 1.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 1.8 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.2 | 0.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 2.0 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 4.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 0.2 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.2 | 1.2 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.2 | 1.2 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 0.2 | GO:0035900 | response to isolation stress(GO:0035900) |
0.2 | 1.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 5.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 1.9 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.2 | 7.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.3 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.2 | 0.7 | GO:0097056 | selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
0.2 | 1.4 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.2 | 0.5 | GO:0006900 | membrane budding(GO:0006900) |
0.2 | 0.5 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
0.2 | 0.8 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 1.3 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 2.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 1.7 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 1.5 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 1.5 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.2 | 1.7 | GO:0071499 | cellular response to laminar fluid shear stress(GO:0071499) |
0.2 | 1.3 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 1.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 1.0 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.2 | 1.8 | GO:0071107 | response to parathyroid hormone(GO:0071107) cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 0.5 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 2.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 1.0 | GO:0043542 | endothelial cell migration(GO:0043542) |
0.2 | 0.8 | GO:0071459 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.2 | 0.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 0.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.2 | 0.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 5.6 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 1.3 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
0.2 | 0.3 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 0.2 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
0.2 | 0.2 | GO:1904884 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.2 | 0.9 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.2 | 5.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.2 | 0.6 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.2 | 1.2 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.2 | 0.3 | GO:0036017 | response to erythropoietin(GO:0036017) |
0.2 | 2.6 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.2 | 0.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.2 | 1.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 0.8 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.5 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
0.2 | 13.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.1 | 0.4 | GO:0046618 | drug export(GO:0046618) |
0.1 | 1.3 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.1 | 2.2 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 2.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.9 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.1 | 0.7 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.1 | 1.5 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.1 | 0.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.4 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.1 | 0.6 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.1 | 0.9 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.1 | 0.3 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.7 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 0.9 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.3 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.9 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 1.2 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
0.1 | 1.4 | GO:0038127 | ERBB signaling pathway(GO:0038127) |
0.1 | 0.3 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
0.1 | 0.3 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.1 | 1.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 0.8 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.1 | 1.0 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 1.0 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 0.7 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.4 | GO:1905229 | thyroid-stimulating hormone signaling pathway(GO:0038194) cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
0.1 | 0.6 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.4 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 2.1 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.1 | 2.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.8 | GO:0018032 | protein amidation(GO:0018032) |
0.1 | 0.7 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 2.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.5 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.1 | 0.4 | GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
0.1 | 0.5 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
0.1 | 0.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 3.0 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 1.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 1.8 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 0.4 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.1 | GO:0001890 | placenta development(GO:0001890) |
0.1 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.3 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.1 | 0.5 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.4 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.1 | 0.4 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.1 | 1.1 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.4 | GO:0019516 | lactate oxidation(GO:0019516) |
0.1 | 1.2 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.1 | 0.5 | GO:0033082 | extrathymic T cell differentiation(GO:0033078) regulation of extrathymic T cell differentiation(GO:0033082) |
0.1 | 2.4 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.1 | 6.3 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 0.5 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.5 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.4 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 0.9 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.1 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.1 | 0.3 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.4 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.1 | 0.1 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 0.9 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.1 | 1.3 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.4 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.9 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.4 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 6.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 3.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.5 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 1.2 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.4 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
0.1 | 0.6 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 1.0 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.2 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 1.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 1.1 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.1 | 0.2 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.2 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 1.2 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.7 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0021897 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
0.1 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 0.2 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.1 | 0.2 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.1 | 0.3 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.1 | 1.0 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 | 0.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 1.4 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.1 | GO:0043200 | response to amino acid(GO:0043200) |
0.1 | 0.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 6.4 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 1.0 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.1 | 0.4 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 2.1 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.9 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.6 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.3 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.1 | 0.1 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
0.1 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.8 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.1 | 2.6 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 0.8 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.1 | 2.5 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.1 | 0.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 1.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.2 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.1 | 0.8 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 1.6 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
0.1 | 0.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 3.2 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.1 | 0.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 8.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 2.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 2.4 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 1.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 3.5 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.1 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.1 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
0.1 | 0.4 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.3 | GO:1901535 | regulation of DNA demethylation(GO:1901535) |
0.1 | 0.1 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.1 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 2.1 | GO:0098743 | cell aggregation(GO:0098743) |
0.1 | 1.0 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.3 | GO:0002371 | dendritic cell cytokine production(GO:0002371) myeloid dendritic cell cytokine production(GO:0002372) |
0.1 | 3.3 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 0.2 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.8 | GO:0030204 | proteoglycan metabolic process(GO:0006029) chondroitin sulfate metabolic process(GO:0030204) chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.1 | 0.6 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 3.9 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 8.5 | GO:0007338 | single fertilization(GO:0007338) |
0.1 | 0.7 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.3 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.4 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.1 | 0.3 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.1 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
0.1 | 1.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.3 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.1 | 0.7 | GO:0010224 | response to UV-B(GO:0010224) |
0.1 | 3.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.7 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.1 | 0.1 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
0.1 | 0.3 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.1 | 0.8 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 1.4 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
0.1 | 0.3 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.1 | 0.4 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.5 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.3 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.4 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.1 | 0.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 1.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.4 | GO:0016128 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.1 | 0.1 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.1 | 0.2 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.3 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
0.1 | 0.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.9 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 0.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.1 | 1.9 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.1 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 0.2 | GO:1904238 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.1 | 1.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 1.6 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.2 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.1 | 0.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 0.4 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 0.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 0.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.2 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.1 | 1.7 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.3 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.1 | 0.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 0.1 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
0.1 | 0.2 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.1 | 0.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.3 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.1 | 1.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 3.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.5 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 1.6 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.2 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.1 | 1.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.2 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.1 | 0.5 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.1 | 0.5 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.1 | 2.0 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.2 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.1 | 1.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.4 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.1 | 0.2 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.1 | 0.9 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 1.3 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 1.7 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 10.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.8 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.1 | GO:1903214 | regulation of protein targeting to mitochondrion(GO:1903214) |
0.1 | 0.1 | GO:0061386 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 0.4 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.4 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.1 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.4 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 0.3 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 1.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.1 | GO:1903708 | positive regulation of hemopoiesis(GO:1903708) |
0.1 | 0.3 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.6 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.8 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.3 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.1 | 0.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 2.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.3 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.1 | 0.5 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.2 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 0.9 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.1 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.3 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.6 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.1 | 0.3 | GO:0051030 | snRNA transport(GO:0051030) |
0.1 | 0.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 2.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.5 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.1 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.1 | 0.4 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.1 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.1 | GO:0018393 | internal peptidyl-lysine acetylation(GO:0018393) |
0.1 | 0.1 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 1.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.2 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.1 | 0.2 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.1 | 0.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.2 | GO:0051167 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
0.1 | 0.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.1 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.6 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.1 | 0.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.5 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.1 | 0.1 | GO:0055006 | cardiac cell development(GO:0055006) cardiac muscle cell development(GO:0055013) |
0.1 | 0.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.5 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.1 | 0.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.1 | 0.4 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.5 | GO:0046006 | regulation of activated T cell proliferation(GO:0046006) |
0.1 | 0.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.5 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.1 | 0.6 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.2 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.1 | 0.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 0.9 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.1 | 0.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.8 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.3 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.1 | 0.2 | GO:1900125 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) regulation of hyaluronan biosynthetic process(GO:1900125) positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.1 | 0.1 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.1 | 0.2 | GO:0061383 | trabecula morphogenesis(GO:0061383) |
0.1 | 0.4 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.6 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.2 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 2.1 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.1 | 0.2 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 1.6 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.7 | GO:0038066 | p38MAPK cascade(GO:0038066) |
0.1 | 0.3 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.1 | 0.4 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 1.9 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.1 | 0.4 | GO:1990089 | response to nerve growth factor(GO:1990089) |
0.1 | 0.8 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 1.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.1 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.1 | 0.2 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.2 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 5.2 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.5 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.1 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.1 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 1.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.1 | 0.1 | GO:0051645 | Golgi localization(GO:0051645) |
0.1 | 0.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.9 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 2.0 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.4 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.0 | 0.1 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.1 | GO:0031247 | actin rod assembly(GO:0031247) |
0.0 | 0.4 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.0 | 1.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.5 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.2 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.0 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.0 | 0.5 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.0 | 0.1 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.0 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.0 | 0.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 1.0 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 4.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.3 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.1 | GO:0009206 | purine nucleoside triphosphate biosynthetic process(GO:0009145) purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
0.0 | 0.1 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.3 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.0 | 0.1 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
0.0 | 0.2 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.0 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.0 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 3.2 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.0 | 0.3 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.6 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.0 | 0.4 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.0 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.7 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.1 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.0 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.2 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.0 | 0.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.0 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.1 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.0 | 1.7 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.0 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.0 | 0.2 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.0 | 0.2 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 0.0 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.0 | 0.1 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.2 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.1 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.0 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.6 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.0 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.0 | 0.2 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.3 | GO:0048639 | positive regulation of developmental growth(GO:0048639) |
0.0 | 0.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.0 | 0.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.0 | 0.0 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.0 | 0.1 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.0 | 0.2 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 1.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.7 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 1.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.1 | GO:0040029 | regulation of gene expression, epigenetic(GO:0040029) |
0.0 | 0.2 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.0 | 0.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.0 | 0.1 | GO:0046931 | pore complex assembly(GO:0046931) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.2 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.1 | GO:0002188 | translation reinitiation(GO:0002188) |
0.0 | 0.2 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.1 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.0 | 0.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.0 | 0.1 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 0.6 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.0 | 0.1 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.0 | 0.1 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.0 | 0.3 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.3 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.1 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.0 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.2 | GO:0090398 | cellular senescence(GO:0090398) |
0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.2 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.0 | 0.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.1 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.0 | 0.1 | GO:0032639 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.0 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.1 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.0 | 2.4 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.0 | 0.2 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.0 | 0.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.3 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.5 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.2 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 0.1 | GO:0001999 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
0.0 | 0.1 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.0 | 0.1 | GO:0061485 | memory T cell proliferation(GO:0061485) |
0.0 | 0.0 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.0 | 0.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.2 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.0 | 0.3 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.2 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.4 | GO:0006817 | phosphate ion transport(GO:0006817) phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.5 | GO:0003016 | respiratory system process(GO:0003016) |
0.0 | 0.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.1 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.0 | 0.1 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.0 | 0.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.1 | GO:0044144 | modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.0 | 0.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.3 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.1 | GO:0032218 | riboflavin transport(GO:0032218) |
0.0 | 0.1 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.0 | 0.0 | GO:1903299 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
0.0 | 1.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.1 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.0 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.0 | 0.1 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.4 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.0 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.0 | 0.0 | GO:0051495 | positive regulation of cytoskeleton organization(GO:0051495) |
0.0 | 0.3 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.1 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.2 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.1 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
0.0 | 0.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
0.0 | 0.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.0 | 0.2 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
0.0 | 0.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.0 | GO:0045912 | negative regulation of carbohydrate metabolic process(GO:0045912) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.4 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.4 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) |
0.0 | 0.0 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.0 | 0.1 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.0 | 0.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.1 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.4 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 0.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.0 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.0 | 0.1 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.5 | 73.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
6.8 | 47.3 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
3.3 | 10.0 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
3.1 | 34.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
2.9 | 14.7 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
2.2 | 26.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.9 | 15.2 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
1.7 | 45.4 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
1.6 | 4.9 | GO:0005595 | collagen type XII trimer(GO:0005595) |
1.5 | 9.1 | GO:0031673 | H zone(GO:0031673) |
1.5 | 112.3 | GO:0001533 | cornified envelope(GO:0001533) |
1.5 | 11.8 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
1.5 | 7.3 | GO:0097179 | protease inhibitor complex(GO:0097179) |
1.4 | 4.3 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
1.4 | 20.8 | GO:0030478 | actin cap(GO:0030478) |
1.4 | 5.4 | GO:0031592 | centrosomal corona(GO:0031592) |
1.3 | 6.4 | GO:0044393 | microspike(GO:0044393) |
1.2 | 3.7 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
1.2 | 3.6 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
1.2 | 5.9 | GO:0031905 | early endosome lumen(GO:0031905) |
1.2 | 5.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.2 | 24.2 | GO:0030056 | hemidesmosome(GO:0030056) |
1.1 | 8.9 | GO:0070876 | SOSS complex(GO:0070876) |
1.0 | 9.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.0 | 4.9 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
1.0 | 20.1 | GO:0042611 | MHC protein complex(GO:0042611) MHC class II protein complex(GO:0042613) |
0.9 | 4.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.9 | 13.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.9 | 4.3 | GO:0031417 | NatC complex(GO:0031417) |
0.8 | 5.1 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.8 | 3.4 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.8 | 8.2 | GO:0032010 | phagolysosome(GO:0032010) |
0.8 | 1.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.8 | 4.8 | GO:0045177 | apical part of cell(GO:0045177) |
0.8 | 4.0 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.8 | 6.9 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.8 | 1.5 | GO:0008091 | spectrin(GO:0008091) |
0.8 | 1.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.8 | 17.3 | GO:0043203 | axon hillock(GO:0043203) |
0.7 | 0.7 | GO:0070993 | translation preinitiation complex(GO:0070993) |
0.7 | 2.8 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.7 | 12.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.7 | 2.8 | GO:1990742 | microvesicle(GO:1990742) |
0.7 | 6.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.7 | 24.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.7 | 6.0 | GO:0016013 | syntrophin complex(GO:0016013) |
0.7 | 8.6 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.7 | 2.6 | GO:0031213 | RSF complex(GO:0031213) |
0.7 | 2.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.7 | 5.9 | GO:0035976 | AP1 complex(GO:0035976) |
0.6 | 9.7 | GO:0045180 | basal cortex(GO:0045180) |
0.6 | 2.6 | GO:0043194 | axon initial segment(GO:0043194) |
0.6 | 21.2 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.6 | 1.9 | GO:0000502 | proteasome complex(GO:0000502) |
0.6 | 17.1 | GO:0005922 | connexon complex(GO:0005922) |
0.6 | 1.3 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.6 | 1.2 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.6 | 4.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.6 | 0.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.6 | 2.5 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.6 | 0.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.6 | 3.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.6 | 4.9 | GO:0070847 | core mediator complex(GO:0070847) |
0.6 | 1.8 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.6 | 3.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.6 | 21.8 | GO:0071437 | invadopodium(GO:0071437) |
0.6 | 4.5 | GO:0002177 | manchette(GO:0002177) |
0.6 | 2.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.5 | 13.1 | GO:0097386 | glial cell projection(GO:0097386) |
0.5 | 1.6 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.5 | 1.6 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.5 | 1.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 1.1 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.5 | 2.1 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.5 | 16.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.5 | 1.5 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.5 | 2.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 2.5 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.5 | 0.5 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.5 | 1.5 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.5 | 1.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.5 | 1.4 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.5 | 0.5 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.5 | 14.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.5 | 1.0 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.5 | 3.8 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.5 | 16.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.5 | 1.9 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.5 | 4.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.5 | 1.4 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.5 | 5.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 3.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 2.2 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.4 | 1.7 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.4 | 1.3 | GO:0089701 | U2AF(GO:0089701) |
0.4 | 33.0 | GO:0045095 | keratin filament(GO:0045095) |
0.4 | 1.7 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.4 | 2.8 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.4 | 13.3 | GO:0043034 | costamere(GO:0043034) |
0.4 | 18.2 | GO:0097228 | sperm principal piece(GO:0097228) |
0.4 | 25.7 | GO:0002102 | podosome(GO:0002102) |
0.4 | 1.2 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.4 | 10.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 1.5 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
0.4 | 0.8 | GO:0055087 | Ski complex(GO:0055087) |
0.4 | 1.8 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.4 | 4.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.4 | 1.5 | GO:0036128 | CatSper complex(GO:0036128) |
0.4 | 0.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.4 | 7.2 | GO:0090543 | Flemming body(GO:0090543) |
0.4 | 40.7 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.4 | 40.1 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.3 | 11.2 | GO:0005605 | basal lamina(GO:0005605) |
0.3 | 1.0 | GO:0097444 | spine apparatus(GO:0097444) |
0.3 | 4.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 7.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 6.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 1.0 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) proton-transporting ATP synthase complex(GO:0045259) |
0.3 | 1.7 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.3 | 3.0 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.3 | 1.3 | GO:0071546 | pi-body(GO:0071546) |
0.3 | 2.0 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 45.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 3.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 7.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 1.0 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.3 | 4.0 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.3 | 3.4 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.3 | 1.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 12.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 0.3 | GO:0034448 | EGO complex(GO:0034448) |
0.3 | 6.0 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 1.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 3.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 0.9 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 2.3 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.3 | 0.6 | GO:0001740 | Barr body(GO:0001740) |
0.3 | 0.3 | GO:0034702 | ion channel complex(GO:0034702) |
0.3 | 1.4 | GO:0071547 | piP-body(GO:0071547) |
0.3 | 7.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 1.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.3 | 23.9 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 2.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 2.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.3 | 3.3 | GO:0000243 | commitment complex(GO:0000243) |
0.3 | 0.5 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.3 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 5.4 | GO:0000974 | Prp19 complex(GO:0000974) |
0.3 | 1.3 | GO:1990462 | omegasome(GO:1990462) |
0.3 | 0.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 2.1 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.3 | 1.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 6.7 | GO:0030135 | coated vesicle(GO:0030135) |
0.3 | 2.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 0.8 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.3 | 1.0 | GO:1990745 | EARP complex(GO:1990745) |
0.3 | 4.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 2.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.3 | 3.0 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 0.3 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.2 | 1.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 3.0 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 2.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 2.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 5.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 1.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 11.6 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 0.5 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 5.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 0.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 0.5 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.2 | 8.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 3.0 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.2 | 0.2 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.2 | 3.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 0.7 | GO:0044301 | climbing fiber(GO:0044301) parallel fiber(GO:1990032) |
0.2 | 2.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.6 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.2 | 1.1 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.2 | 1.8 | GO:0071664 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
0.2 | 1.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 1.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 2.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 0.8 | GO:0070985 | TFIIK complex(GO:0070985) |
0.2 | 1.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 0.4 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.2 | 1.2 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 14.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 14.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 19.2 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.6 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.2 | 1.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 1.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 0.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 4.6 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 2.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 3.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 1.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 3.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.9 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.2 | 31.1 | GO:0016605 | PML body(GO:0016605) |
0.2 | 2.6 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 1.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 1.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 0.5 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 0.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 0.7 | GO:0060187 | cell pole(GO:0060187) |
0.2 | 0.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 5.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 6.4 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 1.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 2.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 0.9 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.2 | 3.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 10.2 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.2 | 1.0 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 0.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 0.2 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.2 | 1.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 1.8 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.2 | 13.2 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.2 | 1.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 4.5 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 3.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.8 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 7.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 2.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 3.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 3.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 16.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 1.2 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.2 | 1.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.2 | 2.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 10.6 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 2.0 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.1 | 0.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.4 | GO:0014802 | terminal cisterna(GO:0014802) ryanodine receptor complex(GO:1990425) |
0.1 | 2.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 3.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.6 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.1 | 4.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.6 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.9 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 56.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.6 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.1 | 3.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 1.0 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.3 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 1.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 1.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 3.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 20.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 7.2 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 2.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 17.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.9 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 2.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.5 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 0.7 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 3.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 1.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 2.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.6 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 1.0 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.2 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 1.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.4 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.2 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.1 | 0.9 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 0.9 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 1.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 8.8 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.6 | GO:0032044 | DSIF complex(GO:0032044) |
0.1 | 0.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 13.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 2.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 9.9 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 1.6 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 25.1 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 1.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.6 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 0.3 | GO:0018444 | translation release factor complex(GO:0018444) |
0.1 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 1.4 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.7 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 4.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 2.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 1.9 | GO:0071010 | prespliceosome(GO:0071010) |
0.1 | 0.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 2.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 3.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.8 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.6 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 4.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 1.9 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.1 | 1.8 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 3.9 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 6.1 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.4 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 1.5 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 1.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 3.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 6.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.6 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 1.7 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 0.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.3 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.2 | GO:0001534 | radial spoke(GO:0001534) |
0.1 | 0.6 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 8.4 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.2 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 1.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 1.3 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.1 | 0.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 2.5 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 0.2 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.1 | 24.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.3 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.1 | 0.1 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 0.1 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.2 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.0 | 0.7 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.4 | GO:0031094 | platelet dense tubular network(GO:0031094) platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.2 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.0 | 0.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 3.3 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 1.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.7 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.4 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.2 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.2 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.0 | 0.2 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.0 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 2.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.3 | GO:0005844 | polysome(GO:0005844) |
0.0 | 1.7 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 1.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.0 | 6.6 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.3 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 1.3 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.5 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.2 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 0.9 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.2 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 0.2 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.0 | 0.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 1.9 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.0 | 1.7 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 3.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 1.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 1.8 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 3.4 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 1.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 1.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.4 | GO:0036019 | endolysosome(GO:0036019) |
0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 4.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 2.8 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.3 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 1.7 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.0 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.2 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.0 | GO:0098855 | HCN channel complex(GO:0098855) |
0.0 | 4.7 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 0.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.1 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.2 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 0.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 16.3 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
5.4 | 26.9 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
4.9 | 14.6 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
4.0 | 12.1 | GO:0002113 | interleukin-33 binding(GO:0002113) |
3.0 | 45.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
2.9 | 14.7 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
2.9 | 8.8 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
2.5 | 7.6 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
2.4 | 38.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
2.4 | 11.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
2.3 | 15.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
2.2 | 8.8 | GO:0035501 | MH1 domain binding(GO:0035501) |
2.1 | 31.3 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
2.0 | 2.0 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
2.0 | 34.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
2.0 | 9.9 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
1.9 | 5.8 | GO:1990254 | keratin filament binding(GO:1990254) |
1.9 | 7.8 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
1.9 | 16.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.8 | 9.1 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
1.8 | 5.3 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
1.7 | 23.7 | GO:0089720 | caspase binding(GO:0089720) |
1.6 | 4.9 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
1.6 | 19.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.6 | 4.8 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
1.6 | 4.7 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
1.6 | 4.7 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
1.5 | 6.2 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
1.5 | 9.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.5 | 5.8 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.4 | 7.1 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
1.4 | 8.3 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
1.4 | 6.9 | GO:0004556 | alpha-amylase activity(GO:0004556) |
1.3 | 4.0 | GO:0030984 | kininogen binding(GO:0030984) |
1.3 | 5.3 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
1.3 | 6.6 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
1.2 | 23.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.2 | 6.1 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
1.2 | 16.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.2 | 13.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.2 | 11.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.2 | 4.7 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
1.2 | 22.2 | GO:0019841 | retinol binding(GO:0019841) |
1.1 | 3.4 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
1.1 | 4.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.1 | 4.4 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
1.1 | 10.8 | GO:0045545 | syndecan binding(GO:0045545) |
1.1 | 3.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
1.1 | 13.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
1.1 | 4.2 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
1.1 | 4.2 | GO:0061714 | folic acid receptor activity(GO:0061714) |
1.0 | 8.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
1.0 | 150.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.0 | 10.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.0 | 2.9 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
1.0 | 3.8 | GO:0008431 | vitamin E binding(GO:0008431) |
0.9 | 21.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.9 | 5.7 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.9 | 18.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.9 | 6.5 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.9 | 3.7 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.9 | 21.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.9 | 29.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.9 | 3.6 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.9 | 10.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.9 | 2.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.9 | 11.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.8 | 2.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.8 | 7.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.8 | 3.3 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.8 | 2.5 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.8 | 15.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.8 | 2.4 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.8 | 2.4 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.8 | 3.2 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.8 | 3.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.8 | 6.8 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.7 | 6.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.7 | 4.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.7 | 11.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.7 | 16.3 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.7 | 1.5 | GO:0070402 | NADPH binding(GO:0070402) |
0.7 | 8.8 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.7 | 7.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.7 | 2.9 | GO:0004641 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
0.7 | 215.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.7 | 4.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.7 | 2.2 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.7 | 6.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.7 | 8.5 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.7 | 8.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.7 | 2.1 | GO:0035326 | enhancer binding(GO:0035326) |
0.7 | 5.5 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.7 | 4.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.7 | 2.7 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.7 | 4.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.7 | 2.7 | GO:0043398 | HLH domain binding(GO:0043398) |
0.7 | 6.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.7 | 2.6 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.6 | 7.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.6 | 19.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.6 | 0.6 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.6 | 2.5 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.6 | 4.4 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.6 | 4.4 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
0.6 | 22.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.6 | 8.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.6 | 3.7 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.6 | 3.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.6 | 22.7 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.6 | 2.4 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.6 | 1.8 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.6 | 3.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.6 | 4.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.6 | 19.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.6 | 1.8 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.6 | 2.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.6 | 2.4 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.6 | 1.8 | GO:0004040 | amidase activity(GO:0004040) |
0.6 | 0.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.6 | 3.5 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.6 | 1.7 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
0.6 | 2.9 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.6 | 8.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.6 | 6.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.6 | 1.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 7.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.6 | 2.8 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.6 | 5.0 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.6 | 2.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.6 | 5.0 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.6 | 4.4 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.6 | 2.2 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.5 | 3.3 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.5 | 8.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.5 | 1.6 | GO:0086079 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
0.5 | 1.6 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
0.5 | 1.6 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.5 | 5.7 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.5 | 0.5 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.5 | 1.6 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.5 | 3.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.5 | 3.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.5 | 3.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.5 | 1.5 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.5 | 0.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.5 | 2.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.5 | 3.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.5 | 1.0 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.5 | 3.4 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.5 | 5.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.5 | 26.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 6.8 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.5 | 1.0 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.5 | 1.9 | GO:1902379 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
0.5 | 1.4 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.5 | 4.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.5 | 1.4 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.5 | 3.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.5 | 1.9 | GO:1904492 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
0.5 | 1.4 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.5 | 4.2 | GO:0043426 | MRF binding(GO:0043426) |
0.5 | 5.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.5 | 9.3 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.5 | 46.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.4 | 0.9 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.4 | 2.2 | GO:0004532 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity(GO:0004532) |
0.4 | 2.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 4.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.4 | 3.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.4 | 1.8 | GO:0048030 | disaccharide binding(GO:0048030) |
0.4 | 2.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.4 | 2.2 | GO:0004320 | oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) |
0.4 | 4.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.4 | 3.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.4 | 1.7 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.4 | 1.3 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.4 | 15.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 2.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 1.7 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.4 | 4.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.4 | 1.3 | GO:0035643 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
0.4 | 5.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.4 | 1.2 | GO:0019864 | IgG binding(GO:0019864) |
0.4 | 0.8 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.4 | 9.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.4 | 1.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 1.2 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
0.4 | 1.6 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.4 | 1.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.4 | 1.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 1.2 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
0.4 | 3.9 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.4 | 5.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.4 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.4 | 1.9 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.4 | 1.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 0.4 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 24.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 0.8 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 1.1 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.4 | 1.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 1.1 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.4 | 9.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.4 | 1.5 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.4 | 1.5 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.4 | 1.5 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.4 | 5.9 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.4 | 4.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 1.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.4 | 12.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.4 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 1.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.4 | 1.5 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.4 | 1.1 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.4 | 1.8 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 2.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 10.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.4 | 1.1 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.4 | 1.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 4.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 2.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.4 | 9.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 1.4 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.4 | 11.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 4.9 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.3 | 4.5 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 1.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 1.0 | GO:0016768 | spermine synthase activity(GO:0016768) |
0.3 | 1.0 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.3 | 7.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 2.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 17.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.3 | 9.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 1.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.3 | 5.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 0.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.3 | 1.3 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.3 | 1.3 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 0.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.3 | 2.0 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.3 | 0.6 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
0.3 | 1.3 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.3 | 3.5 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.3 | 0.9 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.3 | 0.9 | GO:0008441 | 3'(2'),5'-bisphosphate nucleotidase activity(GO:0008441) |
0.3 | 0.9 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.3 | 2.2 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.3 | 1.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.3 | 0.9 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.3 | 2.1 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.3 | 1.8 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.3 | 1.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.3 | 9.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 3.0 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.3 | 0.6 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.3 | 7.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 5.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 2.9 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.3 | 2.0 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.3 | 1.5 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.3 | 0.3 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.3 | 1.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 3.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 1.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 1.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 0.3 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.3 | 3.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 3.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 5.6 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 2.0 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.3 | 1.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.3 | 3.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 4.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 1.1 | GO:1903135 | cupric ion binding(GO:1903135) |
0.3 | 3.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 11.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 0.8 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
0.3 | 1.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 1.1 | GO:0032427 | GBD domain binding(GO:0032427) |
0.3 | 3.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 0.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.3 | 9.9 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.3 | 2.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 11.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 3.7 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 0.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 1.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 6.0 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 6.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 1.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.3 | 1.8 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.3 | 4.7 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 0.8 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.3 | 20.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.3 | 3.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 1.3 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.3 | 1.3 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.3 | 1.0 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.3 | 1.5 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 2.0 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 1.0 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.2 | 5.7 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.2 | 3.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 1.0 | GO:0030171 | hydrogen ion channel activity(GO:0015252) voltage-gated proton channel activity(GO:0030171) |
0.2 | 0.2 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.2 | 1.0 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.2 | 1.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 1.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 1.4 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.2 | 0.5 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 5.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 12.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 0.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 3.5 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.2 | 1.6 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.2 | 1.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 2.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 3.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 6.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 9.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 5.0 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.2 | 0.9 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.2 | 7.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 3.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 1.8 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 19.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 1.5 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.2 | 1.8 | GO:0042835 | BRE binding(GO:0042835) |
0.2 | 1.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 0.7 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
0.2 | 0.2 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.2 | 1.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 1.7 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 4.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 7.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 70.9 | GO:0060090 | binding, bridging(GO:0060090) |
0.2 | 3.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.6 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.2 | 1.9 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
0.2 | 0.4 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.2 | 1.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.2 | 1.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 0.6 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.2 | 1.0 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 1.0 | GO:0000832 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.2 | 2.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.2 | 2.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 4.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 1.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.2 | 0.8 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.2 | 0.2 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.2 | 2.8 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.6 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.2 | 8.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 6.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.8 | GO:1990175 | EH domain binding(GO:1990175) |
0.2 | 1.2 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.2 | 0.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 0.2 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.2 | 0.8 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.2 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.2 | 4.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 0.2 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.2 | 0.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.4 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 6.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.9 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.2 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) translation regulator activity, nucleic acid binding(GO:0090079) |
0.2 | 0.5 | GO:0070984 | SET domain binding(GO:0070984) |
0.2 | 2.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 4.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.7 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 3.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.2 | 2.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 2.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 1.1 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.2 | 7.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 20.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 1.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.2 | 1.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 0.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 1.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 1.4 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 1.2 | GO:0043532 | angiostatin binding(GO:0043532) |
0.2 | 0.7 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.2 | 5.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 2.9 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 7.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 0.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 1.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 2.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.7 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 0.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 0.7 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
0.2 | 1.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 1.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 1.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 4.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 2.4 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.2 | 1.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 0.6 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 1.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.2 | 0.2 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 1.6 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.2 | 0.8 | GO:0052829 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
0.2 | 0.6 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.2 | 2.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 3.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.6 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.2 | 0.6 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.2 | 1.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 1.2 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.2 | 3.4 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 1.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 5.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.7 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 1.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 4.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 1.5 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 0.9 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 1.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 3.3 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 1.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 2.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 23.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.4 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.1 | 2.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.1 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 5.3 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.1 | 0.4 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.1 | 4.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 1.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 1.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 1.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.8 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.1 | 0.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 2.6 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.4 | GO:0008398 | sterol 14-demethylase activity(GO:0008398) |
0.1 | 0.5 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.1 | 1.0 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 0.7 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.1 | 1.3 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.5 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.1 | 0.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 4.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 1.2 | GO:0032450 | alpha-1,4-glucosidase activity(GO:0004558) maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 0.4 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.1 | 2.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 2.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.6 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.9 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.5 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 1.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.3 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
0.1 | 1.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 1.4 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 3.3 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 1.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 0.5 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 2.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 2.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 2.0 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.1 | 0.6 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 5.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 2.6 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.1 | 4.0 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 1.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 9.9 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 0.4 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 2.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.5 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.3 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.1 | 0.6 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 3.0 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.1 | GO:0031692 | alpha-1B adrenergic receptor binding(GO:0031692) norepinephrine binding(GO:0051380) |
0.1 | 0.4 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 0.7 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 1.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 3.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 2.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.6 | GO:0039552 | RIG-I binding(GO:0039552) |
0.1 | 1.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.3 | GO:0017076 | purine nucleotide binding(GO:0017076) |
0.1 | 0.6 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.4 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 19.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 2.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 1.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.5 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 1.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 0.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.8 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.2 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.1 | 0.4 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.1 | 1.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 1.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 10.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 1.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 1.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.2 | GO:0070568 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) guanylyltransferase activity(GO:0070568) |
0.1 | 1.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 3.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 1.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.4 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 2.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.7 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.2 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 0.8 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 2.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 3.0 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.3 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
0.1 | 1.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 1.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 4.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.3 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.1 | 166.0 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 1.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.1 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.2 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.1 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 2.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.1 | 0.5 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.2 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.1 | 1.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 3.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 1.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.9 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 1.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 46.9 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 1.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 38.1 | GO:0032561 | guanyl ribonucleotide binding(GO:0032561) |
0.1 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.1 | 0.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 1.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 8.9 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.2 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.1 | 0.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 1.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 2.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.1 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.1 | 0.6 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 18.2 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.3 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.1 | 0.3 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.1 | 0.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 1.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 1.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.5 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 0.2 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.1 | 0.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.1 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.1 | 0.1 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 0.4 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.2 | GO:0031071 | cysteine desulfurase activity(GO:0031071) |
0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 1.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.2 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.1 | 0.3 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.1 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.5 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.3 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.6 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 2.9 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.2 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.1 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 1.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 10.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.3 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.0 | 1.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.5 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.2 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.0 | 0.1 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.0 | 0.4 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.0 | 0.1 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.0 | 0.2 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.0 | 0.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 1.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.2 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.0 | 0.3 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 1.3 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 1.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.0 | 0.3 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.2 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 1.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 1.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 1.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 1.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 1.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.2 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
0.0 | 0.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 2.8 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 1.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.4 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 1.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.0 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.2 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.0 | 0.1 | GO:0034057 | RNA strand annealing activity(GO:0033592) RNA strand-exchange activity(GO:0034057) |
0.0 | 0.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.1 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 0.0 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 1.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.0 | 0.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.2 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.0 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 2.9 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.0 | 0.0 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.1 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.0 | 0.1 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.0 | 0.1 | GO:0015368 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.0 | 0.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.0 | 0.9 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.0 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.0 | 0.2 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.0 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.0 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.0 | 0.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.0 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.0 | 1.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 2.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.3 | 36.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.1 | 42.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.9 | 99.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.8 | 59.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.7 | 31.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.7 | 27.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.7 | 33.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.7 | 30.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.6 | 29.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.6 | 201.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.5 | 55.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.5 | 8.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 11.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 1.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 2.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.4 | 24.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 28.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.4 | 0.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.4 | 1.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 3.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 20.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 11.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 2.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 4.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 0.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 11.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 7.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 14.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 5.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 6.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 7.8 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 9.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 1.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 15.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 3.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 3.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 3.2 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 11.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 6.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 10.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 7.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 9.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 2.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 2.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 3.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 2.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 5.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 1.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 5.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 61.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 2.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 1.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 11.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 5.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 2.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 16.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 3.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 3.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 3.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 1.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 4.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.7 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 3.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 2.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 6.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 4.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 2.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 2.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 2.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 2.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 1.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 44.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.3 | 20.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
1.2 | 28.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.1 | 45.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.9 | 9.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.8 | 12.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.7 | 18.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.7 | 9.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.6 | 31.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.6 | 16.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.5 | 13.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.5 | 62.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.5 | 11.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.5 | 8.5 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.5 | 17.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.5 | 33.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 17.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.5 | 15.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.4 | 7.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 0.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.4 | 18.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.4 | 16.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 8.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 9.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 7.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 3.9 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.4 | 11.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.4 | 8.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.4 | 9.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.4 | 1.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 17.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 9.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.3 | 6.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 7.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 6.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 9.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 4.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.3 | 5.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 1.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.3 | 3.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 0.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.3 | 9.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 1.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 11.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 6.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 2.7 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.2 | 0.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 5.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 4.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 4.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 14.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 18.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 2.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 5.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 10.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 2.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 113.8 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.2 | 6.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 10.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 5.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 5.9 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 8.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 2.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 5.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 1.9 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.2 | 2.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 1.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 4.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 4.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 7.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 2.0 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.2 | 9.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 9.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 5.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 2.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 6.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 3.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 1.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 3.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 12.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 3.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 2.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 5.4 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 3.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 1.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 3.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 6.7 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 10.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 19.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.2 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 1.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 2.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 2.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 3.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 3.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 2.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 5.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 0.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 0.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.7 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 3.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 6.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 2.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 2.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 5.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.6 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.1 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.7 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 2.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 2.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 2.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.4 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.0 | 2.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 1.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 1.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.1 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.0 | 0.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |